Search research articles
Contact Us
Filters
Showing results (1-10 of 296) with videos related to
Page
of 30
Sort By:
Urologic Oncology
|
September 7, 2010
Limitations of a contemporary prostate biopsy: the blind march forward
John T Wei
Cancer
|
January 12, 2008
Moving beyond the "1 size fits all" paradigm
John T Wei
The Journal of Urology
|
October 22, 2013
How much worse will my voiding symptoms get over time?
John T Wei
Current Opinion in Urology
|
November 19, 2014
Urinary biomarkers for prostate cancer
John T Wei
Urology
|
March 26, 2013
Editorial comment
Rebekah Beach, John T Wei
Seminars in Urologic Oncology
|
February 6, 2002
Shared decision-making strategies for early prostate cancer
John T Wei, Robert G Uzzo
Reviews in Urology
|
December 19, 2006
Economic impact of surgical intervention in the treatment of benign prostatic hyperplasia
John M Hollingsworth, John T Wei
Urology
|
October 1, 2013
Reply by the authors
Florian R Schroeck, John T Wei
Seminars in Urologic Oncology
|
February 6, 2002
Prostate cancer and the educated consumer
Robert G Uzzo, John T Wei
Current Opinion in Urology
|
November 3, 2009
Does the combination of an alpha1-adrenergic antagonist with a 5alpha-reductase inhibitor improve urinary symptoms more than either monotherapy?
John M Hollingsworth, John T Wei
Page
of 30
Search research articles
Search
Showing results (1-10 of 296) with videos related to
Sort By:
Page
of 30
Urologic Oncology
|
September 7, 2010
Limitations of a contemporary prostate biopsy: the blind march forward
John T Wei
Cancer
|
January 12, 2008
Moving beyond the "1 size fits all" paradigm
John T Wei
The Journal of Urology
|
October 22, 2013
How much worse will my voiding symptoms get over time?
John T Wei
Current Opinion in Urology
|
November 19, 2014
Urinary biomarkers for prostate cancer
John T Wei
Urology
|
March 26, 2013
Editorial comment
Rebekah Beach, John T Wei
Seminars in Urologic Oncology
|
February 6, 2002
Shared decision-making strategies for early prostate cancer
John T Wei, Robert G Uzzo
Reviews in Urology
|
December 19, 2006
Economic impact of surgical intervention in the treatment of benign prostatic hyperplasia
John M Hollingsworth, John T Wei
Urology
|
October 1, 2013
Reply by the authors
Florian R Schroeck, John T Wei
Seminars in Urologic Oncology
|
February 6, 2002
Prostate cancer and the educated consumer
Robert G Uzzo, John T Wei
Current Opinion in Urology
|
November 3, 2009
Does the combination of an alpha1-adrenergic antagonist with a 5alpha-reductase inhibitor improve urinary symptoms more than either monotherapy?
John M Hollingsworth, John T Wei
Page
of 30